D. KARADOĞAN Et Al. , "Clinical implications of the SERPINA1 variant, MPalermo, and alpha-1 antitrypsin deficiency in Türkiye," BMC Pulmonary Medicine , vol.24, no.1, 2024
KARADOĞAN, D. Et Al. 2024. Clinical implications of the SERPINA1 variant, MPalermo, and alpha-1 antitrypsin deficiency in Türkiye. BMC Pulmonary Medicine , vol.24, no.1 .
KARADOĞAN, D., Dreger, B., Osaba, L., AHMETOĞLU, E., ÖZYURT, S., YILMAZ KARA, B., ... HÜRSOY, N.(2024). Clinical implications of the SERPINA1 variant, MPalermo, and alpha-1 antitrypsin deficiency in Türkiye. BMC Pulmonary Medicine , vol.24, no.1.
KARADOĞAN, DİLEK Et Al. "Clinical implications of the SERPINA1 variant, MPalermo, and alpha-1 antitrypsin deficiency in Türkiye," BMC Pulmonary Medicine , vol.24, no.1, 2024
KARADOĞAN, DİLEK Et Al. "Clinical implications of the SERPINA1 variant, MPalermo, and alpha-1 antitrypsin deficiency in Türkiye." BMC Pulmonary Medicine , vol.24, no.1, 2024
KARADOĞAN, D. Et Al. (2024) . "Clinical implications of the SERPINA1 variant, MPalermo, and alpha-1 antitrypsin deficiency in Türkiye." BMC Pulmonary Medicine , vol.24, no.1.
@article{article, author={DİLEK KARADOĞAN Et Al. }, title={Clinical implications of the SERPINA1 variant, MPalermo, and alpha-1 antitrypsin deficiency in Türkiye}, journal={BMC Pulmonary Medicine}, year=2024}